|
2014 Journal Article Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?Hill, David S., Lovat, Penny E. and Haass, Nikolas K. (2014). Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?. Melanoma Management, 1 (2), 127-137. doi: 10.2217/MMT.14.16 |
|
2014 Journal Article Targeting glutamine transport to suppress melanoma cell growthWang, Qian, Beaumont, Kimberley A., Otte, Nicholas J., Font, Josep, Bailey, Charles G., van Geldermalsen, Michelle, Sharp, Danae M., Tiffen, Jessamy C., Ryan, Renae M., Jormakka, Mika, Haass, Nikolas K., Rasko, John E. J. and Holst, Jeff (2014). Targeting glutamine transport to suppress melanoma cell growth. International Journal of Cancer, 135 (5), 1060-1071. doi: 10.1002/ijc.28749 |
|
2014 Journal Article Real-time cell cycle imaging during melanoma growth, invasion, and drug responseHaass, Nikolas K., Beaumont, Kimberley A., Hill, David S., Anfosso, Andrea, Mrass, Paulus, Munoz, Marcia A., Kinjyo, Ichiko and Weninger, Wolfgang (2014). Real-time cell cycle imaging during melanoma growth, invasion, and drug response. Pigment Cell and Melanoma Research, 27 (5), 764-776. doi: 10.1111/pcmr.12274 |
|
2014 Journal Article Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up studyMoloney, Fergal J., Guitera, Pascale, Coates, Elliot, Haass, Nikolas K., Ho, Kenneth, Khoury, Ritta, O'Connell, Rachel L., Raudonikis, Leo, Schmid, Helen, Mann, Graham J. and Menzies, Scott W. (2014). Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatology, 150 (8), 819-827. doi: 10.1001/jamadermatol.2014.514 |
|
2014 Journal Article Melanoma never says dieHaass, Nikolas K. and Schumacher, Udo (2014). Melanoma never says die. Experimental Dermatology, 23 (7), 471-472. doi: 10.1111/exd.12400 |
|
2014 Journal Article Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapyMohana-Kumaran, Nethia, Hill, David S., Allen, John D. and Haass, Nikolas K. (2014). Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy. Pigment Cell and Melanoma Research, 27 (4), 525-539. doi: 10.1111/pcmr.12242 |
|
2013 Journal Article Modeling Melanoma In Vitro and In VivoBeaumont, Kimberley A., Mohana-Kumaran, Nethia and Haass, Nikolas K. (2013). Modeling Melanoma In Vitro and In Vivo. Healthcare, 2 (1), 27-46. doi: 10.3390/healthcare2010027 |
|
2013 Journal Article DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.Pavey, Sandra, Spoerri, Loredana, Haass, Nikolas K. and Gabrielli, Brian (2013). DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.. Pigment Cell and Melanoma Research, 26 (6), 805-816. doi: 10.1111/pcmr.12136 |
|
2013 Journal Article A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopyTong, P. L., Qin, J., Cooper, C. L., Lowe, P. M., Murrell, D. F., Kossard, S., Ng, L. G., Roediger, B., Weninger, W. and Haass, N. K. (2013). A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy. British Journal of Dermatology, 169 (4), 869-879. doi: 10.1111/bjd.12430 |
|
2013 Journal Article A novel class of anticancer compounds targets the actin cytoskeleton in tumor cellsStehn, Justine R., Haass, Nikolas K., Bonello, Teresa, Desouza, Melissa, Kottyan, Gregg, Treutlein, Herbert, Zeng, Jun, Nascimento, Paula R. B. B., Sequeira, Vanessa B., Butler, Tanya L., Allanson, Munif, Fath, Thomas, Hill, Timothy A., McCluskey, Adam, Schevzov, Galina, Palmer, Stephen J., Hardeman, Edna C., Winlaw, David, Reeve, Vivienne E., Dixon, Ian, Weninger, Wolfgang, Cripe, Timothy P. and Gunning, Peter W. (2013). A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Research, 73 (16), 5169-5182. doi: 10.1158/0008-5472.CAN-12-4501 |
|
2013 Journal Article The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistanceWroblewski, David, Mijatov, Branka, Mohana- Kumaran, Nethia, Lai, Fritz, Gallagher, Stuart J., Haass, Nikolas K., Zhang, Xu Dong and Hersey, Peter (2013). The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance. Carcinogenesis, 34 (2), 237-247. doi: 10.1093/carcin/bgs330 |
|
2013 Journal Article Melanoma's connections to the tumour microenvironmentBrandner, Johanna M. and Haass, Nikolas K. (2013). Melanoma's connections to the tumour microenvironment. Pathology, 45 (5), 443-452. doi: 10.1097/PAT.0b013e328363b3bd |
|
2012 Journal Article Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737Lucas, Keryn M., Mohana-Kumaran, Nethia, Lau, Diana, Zhang, Xu Dong, Hersey, Peter, Huang, David C., Weninger, Wolfgang, Haass, Nikolas K. and Allen, John D. (2012). Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. Clinical Cancer Research, 18 (3), 783-795. doi: 10.1158/1078-0432.CCR-11-1166 |
|
2011 Journal Article Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010Hersey, P., Smalley, K. S., Weeraratna, A., Bosenberg, M., Zhang, X. D., Haass, N. K., Paton, E., Mann, G., Scolyer, R. A. and Tüting, T. (2011). Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. Pigment Cell and Melanoma Research, 24 (1), e1-e15. doi: 10.1111/j.1755-148X.2010.00811.x |
|
2011 Journal Article Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assayMcGowan, Eileen M., Alling, Nikki, Jackson, Elise A., Yagoub, Daniel, Haass, Nikolas K., Allen, John D. and Martinello-Wilks, Rosetta (2011). Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS ONE, 6 (6) e20623, e20623.1-e20623.8. doi: 10.1371/journal.pone.0020623 |
|
2010 Journal Article Genetics of basal cell carcinomaDe Zwaan, Sally E. and Haass, Nikolas K. (2010). Genetics of basal cell carcinoma. Australasian Journal of Dermatology, 51 (2), 81-92. doi: 10.1111/j.1440-0960.2009.00579.x |
|
2010 Journal Article Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibilityCocciolone, Raymond A., Crotty, Kerry A., Andrews, Lesley, Haass, Nikolas K. and Moloney, Fergal J. (2010). Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. Archives of Dermatology, 146 (11), 1316-1318. doi: 10.1001/archdermatol.2010.333 |
|
2010 Journal Article Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironmentHaass, Nikolas K., Ripperger, D., Wladykowski, E., Dawson, P., Gimotty, P. A., Blome, C., Fischer, F., Schmage, P., Moll, I. and Brandner, Johanna M. (2010). Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment. Histochemistry and Cell Biology, 133 (1), 113-124. doi: 10.1007/s00418-009-0654-5 |
|
2010 Journal Article PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasLee, John T., Li, Ling, Brafford, Patricia A., Van Den Eijnden, Marcia, Halloran, Molly B., Sproesser, Katrin, Haass, Nikolas K., Smalley, Keiran S. M., Tsai, James, Bollag, Gideon and Herlyn, Meenhard (2010). PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell and Melanoma Research, 23 (6), 820-827. doi: 10.1111/j.1755-148X.2010.00763.x |
|
2009 Journal Article Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to TherapyHaass, Nikolas K. and Smalley, Keiran S. M. (2009). Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to Therapy. Molecular Diagnosis and Therapy, 13 (5), 283-296. doi: 10.1007/BF03256334 |
